Does use of the MindEar app reduce tinnitus-related distress in patients awaiting tinnitus therapy?

ISRCTN ISRCTN18213400
DOI https://doi.org/10.1186/ISRCTN18213400
Sponsor University College London Hospitals NHS Foundation Trust
Funder ENT UK
Submission date
13/01/2026
Registration date
21/01/2026
Last edited
20/01/2026
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Ear, Nose and Throat
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data
Record updated in last year

Plain English summary of protocol

Background and study aims
Research has shown that cognitive behavioural therapy (CBT) is effective in reducing the amount of distress people feel related to their tinnitus. Over the past two decades, CBT delivered online has shown to be effective as well as in-person. MindEar is a mobile phone app designed to help people manage their tinnitus using the principles of CBT.
Waiting lists to see a tinnitus specialist on the NHS tend to be long, and many people with tinnitus become more anxious or distressed while they are waiting for their appointment. The aim of this study is to investigate any effects on tinnitus distress of using the MindEar app while awaiting therapy. This study is taking place in just one hospital. We hope it will help us design a larger-scale study on the same topic in future

Who can participate?
Patients aged 18 years and over who have been referred to the Royal National Ear Nose and Throat Hospital in London because of tinnitus, had a medical assessment with an Ear Nose and Throat doctor and been referred to the Hearing Therapy department for help with their tinnitus.

What does the study involve?
Participants are put into one of two groups. One group is given free access to the MindEar app and instructions to use it regularly (between 5 and 10 minutes every day) for at least eight weeks while waiting for a tinnitus therapy appointment. There are a variety of activities in the app, such as challenging your negative thoughts, listening to nature sounds and learning relaxation exercises. The other group won’t be given access to the app and should not download it.
People in both groups need to fill in a set of questionnaires about their tinnitus and how they are feeling when they join the study, and again 2-3 months later. Those patients who did not get access to the app will be able to download it for free at the end of the study (after they have attended their first hearing therapy appointment).

What are the possible benefits and risks of participating?
Using the MindEar app might help people manage tinnitus better and feel less distressed before attending tinnitus therapy.
It is possible that using the app or filling in the questionnaires might make people think about tinnitus at times when they might not otherwise be thinking about it. Sometimes, people find answering questions about their mental health upsetting.

Where is the study run from?
The study is run from the Royal National Ear Nose and Throat Hospital, which is part of University College London Hospitals NHS Trust (UCLH) (UK)

When is the study starting and how long is it expected to run for?
November 2024 to July 2025

Who is funding the study?
ENT UK

Who is the main contact?
Dr Lucy Handscomb, l.handscomb@ucl.ac.uk

Contact information

Dr Lucy Handscomb
Principal investigator, Scientific, Public

UCL Ear Institute, 332 Gray's Inn Road
London
WC1X 8EE
United Kingdom

ORCiD logoORCID ID 0000-0001-8388-948X
Phone +44 (0)2031089591
Email l.handscomb@ucl.ac.uk

Study information

Primary study designInterventional
AllocationNon-randomized controlled trial
MaskingOpen (masking not used)
ControlDose comparison
AssignmentParallel
PurposeTreatment
Scientific titleDoes use of the MindEar app reduce tinnitus-related distress in patients awaiting tinnitus therapy?
Study acronymSTOP-T
Study objectives
Ethics approval(s)

Approved 29/08/2024, Wales Research Ethics Committee 5 (Health and Care Research Wales, Castlebridge 4, 15-19 Cowbridge Road East, Cardiff, CF11 9AB, United Kingdom; +44 (0)2920 230457; Wales.REC5@wales.nhs.uk), ref: 317132

Health condition(s) or problem(s) studiedTinnitus
InterventionThe digital therapeutic called MindEar- delivered through a mobile app - provides therapies using the principles of Cognitive Behavioural Therapy (CBT), mindfulness, psycho-education and sound therapy.

All participants will be allocated to either an intervention or a control group. For the intervention group, MindEar will be offered after referral (by an audiological physician, ENT surgeon or audiologist) for a tinnitus appointment with a hearing therapist. The control group will simply wait for their appointment with a hearing therapist as usual and will be given the possibility to use MindEar afterwards. All participants will be asked to fill in a set of questionnaires at three timepoints. Anonymised data about app usage will be collected automatically. Participants will be involved for approximately 16 weeks.
Intervention typeBehavioural
Primary outcome measure(s)
  1. Tinnitus distress measured using Tinnitus Functional Index at baseline, 8 weeks, 16 weeks
Key secondary outcome measure(s)
Completion date15/07/2025

Eligibility

Participant type(s)
Age groupMixed
Lower age limit18 Years
Upper age limit100 Years
SexAll
Target sample size at registration60
Total final enrolment76
Key inclusion criteria1. Having prolonged spontaneous tinnitus
2. Having been referred for a hearing therapy appointment at the Royal National Ear, Nose and Throat Hospital, London for tinnitus support
3. Owning and using a smartphone with an internet connection
Key exclusion criteria1. Unable to understand written English
2. Low vision making it impossible to read text on an app
3. Very high tinnitus distress requiring urgent referral
4. Already undergoing tinnitus therapy
Date of first enrolment04/11/2024
Date of final enrolment15/04/2025

Locations

Countries of recruitment

  • United Kingdom
  • England

Study participating centre

Royal National Throat, Nose & Ear Hospital
330 Gray's Inn Road
London
WC1X 8DA
England

Results and Publications

Individual participant data (IPD) Intention to shareNo
IPD sharing plan summaryNot expected to be made available
IPD sharing plan

Editorial Notes

13/01/2026: Study's existence confirmed by the RNENT & EDH Clinical Research Feasibility Committee (CRFC).